Showing results (401-410 of 9,918) with videos related to
Sort By:
Pageof 992
Bone Marrow Transplantation|September 14, 2004
The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosisR K Burt, D Patel, J Thomas, et al.Bone Marrow Transplantation|September 14, 2004
Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazoleV H Bigley, R F Duarte, R D Gosling, et al.Bone Marrow Transplantation|September 14, 2004
Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working PartyI Kataoka, M Kami, S Takahashi, et al.Bone Marrow Transplantation|August 3, 2004
Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myelomaS Kumar, M Q Lacy, A Dispenzieri, et al.Bone Marrow Transplantation|August 3, 2004
Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosisA Altes, A F Remacha, P Sarda, et al.Bone Marrow Transplantation|August 3, 2004
Bone metabolism in patients more than five years after bone marrow transplantationK Kerschan-Schindl, M Mitterbauer, W Füreder, et al.Bone Marrow Transplantation|August 3, 2004
Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stressA M Evens, J Mehta, L I GordonBone Marrow Transplantation|August 1, 1992
Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrowS Gulati, L Acaba, J Yahalom, et al.Bone Marrow Transplantation|August 1, 1992
Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 childrenV Méresse, O Hartmann, G Vassal, et al.Bone Marrow Transplantation|August 1, 1992
Reverse seroconversion of hepatitis B virus infectious status after allogeneic bone marrow transplantation from a carrier donorF S Fan, C H Tzeng, H M Yeh, et al.Pageof 992